Cooperation between action medeorBayerBoehringer Ingelheim and Merck enters second phase

To better protect patients from undesirable side effects of medicines, pharmacists will be more closely involved in Tanzanian clinics. This is the goal of a multi-stakeholder partnership (MSP) launched by action medeorBayerBoehringer Ingelheim and Merck, which is now entering its second phase. In the first phase, a roundtable was initiated in 2017 for uniform and comprehensive training of pharmaceutical assistants and technicians, to ensure the care of patients in rural areas of Tanzania.

The press release of action medeor (in german) can be found here.

This might also interest you:

p2023 news thumbnail
News
Key insights from the event “Together towards effective implementation of CSDDD”  
p2023 news thumbnail
News
Progress in the fight against gender-based violence in Indian textile factories – alliance initiative advocates the extension of the agreement
p2023 news thumbnail
News
Partnerships2030 in Brussels: Working towards an effective implementation of the European Corporate Sustainability Due Diligence Directive (CSDDD)